It is already widely known that the tumour suppressor p53 (a protein) plays a critical role in protecting us from cancer. Much of what we know about p53 comes from the work of Karen Vousden – she discovered the important factor that the loss of p53 played in the development of cervical carcinomas and linked this to a tumour virus that triggers this form of cancer.
Karen’s work also provided major insights into just how p53 is able to suppress tumour development; not only can it stop the proliferation of cancer cells but it can also cause them to suicide through the process of apoptosis.
The potential benefits of Karen’s work, for cancer patients, are enormous in terms of the development of molecules that might be used as drugs to stabilize and activate p53.
Dr Karen Vousden gained her PhD Genetics at University of London and went on to work with Professor Chris Marshall at the Institute of Cancer Research, London for her post-doc research. Further posts with the National Cancer Institute at Bethesda, USA and heading up the Human Papillomavirus Group at the Ludwig Institute for Cancer Research followed by senior positions at the NCI-FCRDC, culminated in her appointment as Director of the Beatson Institute in 2002.
Mark Burgess | alfa
Gut microbiome regulates the intestinal immune system, researchers find
19.12.2018 | Brown University
Greener days ahead for carbon fuels
19.12.2018 | DOE/Lawrence Berkeley National Laboratory
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Materials Sciences
19.12.2018 | Materials Sciences
19.12.2018 | Life Sciences